BE

Belgium

15338 clinical trials

Find Trials

Clinical Trials (15338)

Showing 20 of 15,338 trialsScroll for more

ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

Recruiting
NCT05950945Phase 37 sites

Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer

Recruiting
NCT07318558Phase 33 sites

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

Recruiting
NCT07225569Phase 23 sites

A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Recruiting
NCT07123155Phase 21 site

Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)

Recruiting
NCT04886804Phase 11 site

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

Active Not Recruiting
NCT05215340Phase 34 sites

Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations

Active Not Recruiting
NCT06865417Phase 33 sites

A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis

Recruiting
NCT06430801Phase 33 sites

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Recruiting
NCT07284420Phase 21 site

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

Recruiting
NCT07218029Phase 32 sites

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

Recruiting

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

Recruiting
NCT07218926Phase 31 site

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

Recruiting
NCT07213674Phase 34 sites

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Recruiting
NCT06719141Phase 32 sites

A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)

Recruiting
NCT07227402Phase 34 sites

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

Recruiting
NCT06660394Phase 32 sites

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

Recruiting
NCT03911700Not Applicable1 site

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

Recruiting
NCT06824467Phase 35 sites

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Recruiting
NCT07645196Not Applicable2 sites

Effects of Physiotherapy on Ultrasound and Clinical Parameters in Women With Dysmenorrhea

Not Yet Recruiting